P

Inventor

ZHANG SHUNNAN

CN17 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG SHUNNAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TASLY PHARMACEUTICAL GROUP CO

15 patents
US9999630B2Jun 19, 2018

Traditional chinese medicine composition, and preparation and application thereof

TASLY PHARMACEUTICAL GROUP CO3 citations71
US9987320B2Jun 5, 2018

Traditional chinese medicine composition, and preparation and application thereof

TASLY PHARMACEUTICAL GROUP CO2 citations70
US12090138B2Sep 17, 2024

Pharmaceutical composition containing silybin and VE

TASLY PHARMACEUTICAL GROUP CO0 citations61
US11318112B2May 3, 2022

Pharmaceutical composition containing silybin and ve

TASLY PHARMACEUTICAL GROUP CO0 citations61
USRE49035EApr 19, 2022

Traditional Chinese medicine composition, and preparation and application thereof

TASLY PHARMACEUTICAL GROUP CO0 citations60
USRE49050EApr 26, 2022

Traditional Chinese medicine composition, and preparation and application thereof

TASLY PHARMACEUTICAL GROUP CO0 citations59
US10300030B2May 28, 2019

Traditional Chinese medicine composition

TASLY PHARMACEUTICAL GROUP CO1 citations58
US10507197B2Dec 17, 2019

Pharmaceutical composition containing silibinin

TASLY PHARMACEUTICAL GROUP CO0 citations51
US10376490B2Aug 13, 2019

Pharmaceutical composition containing silybin

TASLY PHARMACEUTICAL GROUP CO0 citations51
US10307396B2Jun 4, 2019

Pharmaceutical composition containing silybin, VE and L-carnitine

TASLY PHARMACEUTICAL GROUP CO0 citations51
US10307395B2Jun 4, 2019

Pharmaceutical composition containing silybin and L-carnitine

TASLY PHARMACEUTICAL GROUP CO0 citations51
US10376491B2Aug 13, 2019

Pharmaceutical composition containing silibinin and pueraria root extract

TASLY PHARMACEUTICAL GROUP CO0 citations50
US11013694B2May 25, 2021

Formulation of a micro drop pill and the preparation method thereof

TASLY PHARMACEUTICAL GROUP CO0 citations48
US9889093B2Feb 13, 2018

Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof

TASLY PHARMACEUTICAL GROUP CO0 citations45
US9795648B2Oct 24, 2017

Pharmaceutical composition for treating headache, and preparation method thereof

TASLY PHARMACEUTICAL GROUP CO0 citations38

TIANJIN KINSLY PHARMACEUTICAL

1 patent

ZHANG SHUNNAN

1 patent